iQ&A for Interventional Cardiology
iQ&A for STEMI Management
iQ&A for Cancer and Thrombosis
iQ&A for Thrombosis Management
iQ&A for DVT and PE
iQ&A for DVT and PE
iQ&A for Thrombosis Management
iQ&A for Cancer and Thrombosis
iQ&A for STEMI Management
iQ&A for Interventional Cardiology
iQ&A for Sepsis
iQ&A for Adolescent Depression
iQ&A for Rheumatoid Arthritis
iQ&A for Cancer and Thrombosis
iQ&A for Sepsis
iQ&A for Adolescent Depression
iQ&A for Adolescent Depression
Play All
Complete FAQ List
Speakers
Michael H. Schiff, MD
Yusuf Yazici, MD
Mark C. Genovese, MD
Allan Gibofsky, MD, JD
Joel M. Kremer, MD
Eric Ruderman, MD
Daniel E. Furst, MD
Yvonne Sherrer, MD
Theresa A. Lawrence Ford, MD
Resources
Program Content and FAQs
ACR Guidelines for Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in RA
Current Evidence for the Management of RA with Biological Disease-Modifying Antirheumatic Drugs
Methotrexate Monotherapy versus Combination Therapy with a Biological Agent in Early RA
Evaluation of Abatacept in Biologic-naive Patients with Active RA
Strategic Approach to the Management of RA with Antirheumatic Drugs
Treatment of RA: Strategies for Optimal Outcomes
Treating RA to Target: International Task Force Recommendations
Updated Consensus Statement on Biological Agents for RA
Submit Questions
About iQ&A
The Science and Medicine of Sepsis Management
New Paradigms in Atrial Fibrillation
Pharmacologic Therapy in the Setting of Parkinson’s Disease
New Dimensions in Hypertension and Heart Disease
Advances in Neuropsychiatric Health
Comprehensive Osteoporosis Management
ClinicalWebcasts.com
OncologyCAST.net
CardioCAST.net
OsteoporosisCAST.com
HypertensionCAST.com
NeuroPsychCAST.com
Updates in Alzheimer's Disease
Updates in Osteoporosis
Updates in Interventional Cardiology
Updates in Thrombosis
Updates in Parkinson's Disease
Updates in Depression
Landmark Advances in Cardiovascular Anesthesiology
Cancer and Thrombosis Management
Comprehensive Osteoporosis Management
GeneticScreeningWRAP: Prenatal Screening for Genetic Disorders
AntiplateletWRAP: Oral Antiplatelet Therapy and PPIs in ACS and CAD
Alzheimer’sWRAP: Foundation Role of Cholinergic Dysregulation in AD